Results 121 to 130 of about 30,112 (235)

A Primary Retroperitoneal Mucinous Tumor

open access: yesCase Reports in Surgery, 2015
A twenty-five-year-old female presented with a large retroperitoneal mass. Workup included history and physical exam, imaging, biopsy, colonoscopy, and gynecologic exam.
Alicia A. Heelan Gladden   +3 more
doaj   +1 more source

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

open access: yesBMC Cancer, 2018
Background The survival of patients with ovarian cancer has improved because of surgery and chemotherapy. This study aimed to estimate the changes in survival rates among Korean women with ovarian cancer prior to the introduction of targeted therapy for ...
Jung-Yun Lee   +8 more
doaj   +1 more source

Tubular Krukenberg Tumor with an Occult Primary [PDF]

open access: yes, 2011
Tubular Krukenberg tumor with an occult primary can cause problems in histopathologic diagnosis, by mimicking primary ovarian tumors. We present one such occurrence in a 32year old female who underwent surgery for bilateral malignant ovarian tumor. Gross
Kaur, N, Kaushal, V, Mardi, K
core   +1 more source

Hiding in plain sight: DICER1‐associated yolk sac tumour masquerading as an endometrioid carcinoma of the ovary

open access: yes
Histopathology, EarlyView.
Lili Fu   +4 more
wiley   +1 more source

Protein glycosylation in lung cancer from a mass spectrometry perspective

open access: yesMass Spectrometry Reviews, Volume 45, Issue 3, Page 455-475, May/June 2026.
ABSTRACT Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi   +2 more
wiley   +1 more source

Metastatic Ovarian Mucinous Carcinoma Presenting as Ileocecal Adenocarcinoma: A Case Report. [PDF]

open access: yesCureus, 2022
Glombicki SE   +5 more
europepmc   +1 more source

Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma [PDF]

open access: yesClinical Cancer Research, 2021
Koji, Matsuo   +23 more
openaire   +2 more sources

Beyond the Usual Suspects: Emerging Associations Between Epstein‐Barr Virus Infection/Infectious Mononucleosis and Cancers

open access: yesReviews in Medical Virology, Volume 36, Issue 3, May 2026.
ABSTRACT Epstein‐Barr virus (EBV) is a ubiquitous herpesvirus and a causal factor for Burkitt Lymphoma (BL), Hodgkin Lymphoma (HL), gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC). Whether EBV contributes to a wider spectrum of cancers remains uncertain.
Marisa D. Muckian   +4 more
wiley   +1 more source

Bilateral ovarian mucinous carcinoma (stage III) with omental involvement and incidental hydronephrosis: A rare case report. [PDF]

open access: yesInt J Surg Case Rep, 2022
Poudel D   +5 more
europepmc   +1 more source

Recent Therapies and Biomarkers in Mucinous Ovarian Carcinoma

open access: yesCells
Mucinous ovarian carcinoma (MOC) represents a rare and biologically distinct subtype of ovarian cancer, characterized by poor response to standard platinum-based chemotherapy and a unique molecular profile, including frequent KRAS mutations and HER2 amplifications. Recent advancements in targeted therapy, such as HER2 inhibitors and KRASG12C inhibitors,
Grzegorz Przywara   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy